← Eichor
Condition: Tumour Of Epithelial Origin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tumour Of Epithelial Origin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours
NA · 1 location(s) · Xijing Hospital · NCT06770478Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRP
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06576037Beyond TME Origins
NA · 4 location(s) · Imperial College London · NCT02292641Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-
Phase N/A · 1 location(s) · University of Washington · NCT06725173Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Phase 1 · 3 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT07517198Bile Omics for Diagnosing Indeterminate Biliary Strictures
Phase N/A · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07007832Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Phase 3 · 6 location(s) · GT Medical Technologies, Inc. · NCT07195591Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00242723
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.